Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)


Phase N/A Results N/A

Eligibility Criteria

For more information regarding BMS clinical trial participation, please visit

Inclusion Criteria

- Adult patients (≥18 years old)
- Patients diagnosed with Non-valvular atrial fibrillation (NVAF) any time prior to the inclusion date (prevalent or incident patients)
- Patients treated or not treated with an antithrombotic therapy
- Treated patients should have begun treatment prior to the inclusion visit
- Patients attending Internal Medicine departments, either for a hospital appointment (outpatients) or hospitalization (inpatients) for any reason)
- Patients which signed the informed consent

Exclusion Criteria

- Patients diagnosed with valvular atrial fibrillation any time in their medical records
- Patients with anticoagulant treatment prescribed for venous thromboembolic disease any time prior to the inclusion date
- Patients which participated in any clinical trial with anticoagulant and/or antiplatelet agents in the previous six months
- Patients incapable of giving their informed consent